[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
[ Thu, Mar 16th 2023 ]: WOPRAI
Andreas Argyrides Reiterated (UBX) at Buy and Held Target at $35 on, Mar 16th, 2023
- 🞛 This publication is a summary or evaluation of another publication
Andreas Argyrides of Wedbush, Reiterated "Unity Biotechnology, Inc." (UBX) at Buy and Held Target at $35 on, Mar 16th, 2023.
Andreas has made no other calls on UBX in the last 4 months.
There is 1 other peer that has a rating on UBX. Out of the 1 peers that are also analyzing UBX, 0 agree with Andreas's Rating of Hold.
This is the rating of the analyst that currently disagrees with Andreas
- Salim Syed of "Mizuho" Maintained at Strong Buy with Decreased Target to $12 on, Wednesday, November 16th, 2022